These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Effect of guanine nucleotides on dopaminergic agonist and antagonist affinity for [3H]sulpiride binding sites in rat striatal membrane preparations. Freedman SB, Poat JA, Woodruff GN. J Neurochem; 1981 Sep; 37(3):608-12. PubMed ID: 7276943 [Abstract] [Full Text] [Related]
30. Dopamine D2 receptor dissociation constant for spiperone: identical values using 3H-labeled agonist or 3H-labeled antagonist. Seeman P, Grigoriadis D. Biochem Pharmacol; 1985 Nov 15; 34(22):4065-6. PubMed ID: 4062976 [No Abstract] [Full Text] [Related]
31. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA. J Pharmacol Exp Ther; 1987 Jan 15; 240(1):167-76. PubMed ID: 3100767 [Abstract] [Full Text] [Related]
32. D-2 dopamine receptors in aging mouse striatum: determination of high- and low-affinity agonist binding sites. Severson JA, Randall PK. J Pharmacol Exp Ther; 1985 May 15; 233(2):361-8. PubMed ID: 3158731 [Abstract] [Full Text] [Related]
33. Binding characteristics of the dopamine agonist/antagonist [3H]terguride (transdihydrolisuride) in the rat striatum. Valchár M, Vrsecká M, Krejcí I, Dlabac A. Eur J Pharmacol; 1987 Apr 07; 136(1):97-101. PubMed ID: 3297739 [Abstract] [Full Text] [Related]
34. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site. Beart PM, Krstich M, McDonald D, Gundlach AL. Neurosci Lett; 1982 Apr 16; 29(2):147-51. PubMed ID: 6123968 [Abstract] [Full Text] [Related]
35. Elevation of acetylcholine levels in striatum of rat brain by LY163502, trans-(-)-5,5a,6,7,8,9a,10-octahydro-6-propylpyrimido less than 4,5-g greater than quinolin-2-amine dihydrochloride, a potent and stereospecific dopamine (D2) agonist. Bymaster FP, Reid LR, Nichols CL, Kornfeld EC, Wong DT. Life Sci; 1986 Jan 27; 38(4):317-22. PubMed ID: 3753738 [Abstract] [Full Text] [Related]
36. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain. Gackenheimer SL, Schaus JM, Gehlert DR. J Pharmacol Exp Ther; 1995 Sep 27; 274(3):1558-65. PubMed ID: 7562534 [Abstract] [Full Text] [Related]
37. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions. List SJ, Seeman P. Proc Natl Acad Sci U S A; 1981 Apr 27; 78(4):2620-4. PubMed ID: 6941314 [Abstract] [Full Text] [Related]
38. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites. Leysen JE, Gommeren W. J Neurochem; 1981 Jan 27; 36(1):201-19. PubMed ID: 7463046 [Abstract] [Full Text] [Related]
39. The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors. Kilpatrick GJ, el Tayar N, Van de Waterbeemd H, Jenner P, Testa B, Marsden CD. Mol Pharmacol; 1986 Sep 27; 30(3):226-34. PubMed ID: 2943980 [Abstract] [Full Text] [Related]
40. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2. Niznik HB, Grigoriadis DE, Pri-Bar I, Buchman O, Seeman P. Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun 27; 329(4):333-43. PubMed ID: 2863760 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]